Effector Therapeutics Competitors and Similar CompaniesClear all
Effector Therapeutics's competitors and similar companies include ImmunoGen and Olema Oncology.
 Effector Therapeutics Effector Therapeutics is a company focused on the discovery and development of small molecule cancer therapeutics. |  ImmunoGen ImmunoGen is a biotechnology company focused on the development of antibody-drug conjugates (ADCs) to improve outcomes for cancer patients. |  Olema Oncology Olema Oncology (also known as Olema Pharmaceuticals) is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for women’s cancers. | |
Founding Date | Founding Date 2012 | Founding Date 1981 | Founding Date 2007 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Solana Beach, US HQ San Diego, US | Locations Waltham, US HQ | Locations San Francisco, US HQ San Francisco, US |
Employees | Employees 27 | Employees 277161% increase | Employees 9630% increase |
Valuation ($) | Valuation ($) 1.9 k | Valuation ($) 8.7 b | Valuation ($) 679.2 m |
Financial | |||
Net income | Net income ($35.8m) (FY, 2023) | Net income ($222.9m) (FY, 2022) | Net income ($162.5m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 101m | Total funding raised $ 56m | Total funding raised $ 145.1m |
For sources of this data, please see the company profile
View Company Profiles
ImmunoGen
HQ
Waltham, US
Employees
277
ImmunoGen is a biotechnology company focused on the development of antibody-drug conjugates (ADCs) to improve outcomes for cancer patients.
View companyOlema Oncology
HQ
San Francisco, US
Employees
96↑ 30% increase
Olema Oncology (also known as Olema Pharmaceuticals) is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for women’s cancers.
View company